1. Home
  2. VSH vs NVAX Comparison

VSH vs NVAX Comparison

Compare VSH & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VSH
  • NVAX
  • Stock Information
  • Founded
  • VSH 1962
  • NVAX 1987
  • Country
  • VSH United States
  • NVAX United States
  • Employees
  • VSH N/A
  • NVAX N/A
  • Industry
  • VSH Electrical Products
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • VSH Technology
  • NVAX Health Care
  • Exchange
  • VSH Nasdaq
  • NVAX Nasdaq
  • Market Cap
  • VSH 2.5B
  • NVAX 2.0B
  • IPO Year
  • VSH N/A
  • NVAX 1995
  • Fundamental
  • Price
  • VSH $18.45
  • NVAX $10.35
  • Analyst Decision
  • VSH Buy
  • NVAX Buy
  • Analyst Count
  • VSH 2
  • NVAX 6
  • Target Price
  • VSH $23.50
  • NVAX $17.83
  • AVG Volume (30 Days)
  • VSH 1.2M
  • NVAX 8.0M
  • Earning Date
  • VSH 11-06-2024
  • NVAX 11-07-2024
  • Dividend Yield
  • VSH 2.17%
  • NVAX N/A
  • EPS Growth
  • VSH N/A
  • NVAX N/A
  • EPS
  • VSH 1.23
  • NVAX N/A
  • Revenue
  • VSH $3,126,407,000.00
  • NVAX $987,667,000.00
  • Revenue This Year
  • VSH N/A
  • NVAX N/A
  • Revenue Next Year
  • VSH $9.89
  • NVAX N/A
  • P/E Ratio
  • VSH $15.01
  • NVAX N/A
  • Revenue Growth
  • VSH N/A
  • NVAX N/A
  • 52 Week Low
  • VSH $17.42
  • NVAX $3.53
  • 52 Week High
  • VSH $24.72
  • NVAX $23.86
  • Technical
  • Relative Strength Index (RSI)
  • VSH 49.81
  • NVAX 36.01
  • Support Level
  • VSH $17.49
  • NVAX $9.62
  • Resistance Level
  • VSH $18.68
  • NVAX $13.34
  • Average True Range (ATR)
  • VSH 0.39
  • NVAX 1.03
  • MACD
  • VSH 0.11
  • NVAX -0.32
  • Stochastic Oscillator
  • VSH 63.40
  • NVAX 13.04

About VSH Vishay Intertechnology Inc.

Vishay Intertechnology Inc provides a broad product portfolio of discrete semiconductors and passive electronic components to original equipment manufacturers and distributors. These products are found in industrial, computing, automotive, consumer, telecommunications, power supplies, military, aerospace, and medical markets and serve customer worldwide. Its product segments consist of two general classes: semiconductors and passive components. The company's operating segment includes metal oxide semiconductor field-effect transistors, diodes, optoelectronic components, resistors, inductors, and capacitors. Revenue mainly comes from resistors, which are basic components used in all forms of electronic circuitry to adjust and regulate levels of voltage and current.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The Company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from Europe.

Share on Social Networks: